LSVMX
Price
$10.33
Change
-$0.07 (-0.67%)
Updated
Jan 22 closing price
Net Assets
22.31M
RMFEX
Price
$56.68
Change
-$0.04 (-0.07%)
Updated
Jan 22 closing price
Net Assets
104.52B
Ad is loading...

LSVMX vs RMFEX

Header iconLSVMX vs RMFEX Comparison
Open Charts LSVMX vs RMFEXBanner chart's image
LSV US Managed Volatility Institutional
Price$10.33
Change-$0.07 (-0.67%)
VolumeN/A
Net Assets22.31M
American Funds American Mutual R4
Price$56.68
Change-$0.04 (-0.07%)
VolumeN/A
Net Assets104.52B
LSVMX vs RMFEX Comparison Chart
Loading...
View a ticker or compare two or three
VS
LSVMX vs. RMFEX commentary
Jan 24, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LSVMX is a Hold and RMFEX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
RMFEX has more cash in the bank: 105B vs. LSVMX (22.3M). LSVMX pays higher dividends than RMFEX: LSVMX (2.27) vs RMFEX (1.95). LSVMX was incepted earlier than RMFEX: LSVMX (11 years) vs RMFEX (23 years). RMFEX is a more actively managed with annual turnover of: 25.00 vs. LSVMX (21.00). RMFEX has a lower initial minimum investment than LSVMX: RMFEX (250) vs LSVMX (100000). RMFEX annual gain was more profitable for investors over the last year : 12.66 vs. LSVMX (2.99). RMFEX return over 5 years is better than : 42.55 vs. LSVMX (-8.77).
LSVMXRMFEXLSVMX / RMFEX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence11 years23 years-
Gain YTD2.2773.20571%
Front LoadN/AN/A-
Min. Initial Investment10000025040,000%
Min. Initial Investment IRAN/AN/A-
Net Assets22.3M105B0%
Annual Yield % from dividends2.271.95116%
Returns for 1 year2.9912.6624%
Returns for 3 years-12.6717.39-73%
Returns for 5 years-8.7742.55-21%
Returns for 10 years21.8371.6530%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SRM0.470.01
+2.59%
SRM Entertainment
IKT2.80-0.01
-0.36%
Inhibikase Therapeutics
GEF61.25-0.93
-1.50%
Greif
VTR58.36-1.93
-3.20%
Ventas
UTL53.05-2.03
-3.69%
Unitil Corp